Pasar al contenido principal

BENEFICIOS Y RIESGOS DE LAS RESPUESTAS INMUNOLOGICAS A LA ISQUEMIA CEREBRAL

SAF2014-56279-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage

  • Pedragosa, Jordi
  • Salas-Perdomo, Angélica
  • Gallizioli, Mattia
  • Cugota, Roger
  • Miró-Mur, Francesc
  • Briansó, Ferran
  • Justicia, Carles
  • Pérez-Asensio, Fernando J.
  • Márquez-Kisinousky, Leonardo
  • Urra, Xabier
  • Gieryng, Anna
  • Kaminska, Bozena
  • Chamorro, Ángel
  • Planas, Anna M.
The central nervous system (CNS) contains several types of immune cells located in specific anatomic compartments. Macrophages reside at the CNS borders surrounding the brain vessels, in leptomeningeal spaces and the choroid plexus, where they interact with the vasculature and play immunological surveillance and scavenging functions. We investigated the phenotypic changes and role of these macrophages in response to acute ischemic stroke. Given that CD163 expression is a hallmark of perivascular and meningeal macrophages in the rat and human brain, we isolated CD163+ brain macrophages by fluorescence activated cell sorting. We obtained CD163+ cells from control rats and 16 h following transient middle cerebral artery occlusion, after verifying that infiltration of CD163+ peripheral myeloid cells is negligible at this acute time point. Transcriptome analysis of the sorted CD163+ cells identified ischemia-induced upregulation of the hypoxia inducible factor-1 pathway and induction of genes encoding for extracellular matrix components and leukocyte chemoattractants, amongst others. Using a cell depletion strategy, we found that CNS border-associated macrophages participate in granulocyte recruitment, promote the expression of vascular endothelial growth factor (VEGF), increase the permeability of pial and cortical blood vessels, and contribute to neurological dysfunction in the acute phase of ischemia/reperfusion. We detected VEGF expression surrounding blood vessels and in some CD163+ perivascular macrophages in the brain tissue of ischemic stroke patients deceased one day after stroke onset. These findings show ischemia-induced reprogramming of the gene expression profile of CD163+ macrophages that has a rapid impact on leukocyte chemotaxis and blood-brain barrier integrity, and promotes neurological impairment in the acute phase of stroke., Supported by the Spanish Ministerio de Economia y Competitividad (SAF2014–56279-R and SAF2017–87459-R). JP and MG were supported by a PhD fellowship from the Catalan Research Agency (AGAUR) and the ITN program of the European Community (NeuroInflammation, FP7-PEOPLE-2013-ITN-n°607962), respectively. FMM is recipient of an ICT award by the Pla estratègic de recerca i innovació en salut (PERIS) of the Departament de Salut, Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension

  • Meissner, Anja
  • Jens Minnerup
  • Soria, Guadalupe
  • Planas, Anna M.
Hypertension is a main risk factor for the development of cerebral small vessel disease (cSVD) – a major contributor to stroke and the most common cause of vascular dementia. Despite the increasing socioeconomic importance arising from cSVD, currently only a few specific treatment strategies with proven efficacy are known. Fundamental to the lack of specific treatments is poor understanding of the disease pathogenesis and a lack of appropriate animal models resembling all symptoms of the human disease. However, chronic hypertensive rat models have been shown to bear similarities to most key features of cSVD. Despite a significantly larger toolbox available for genotypic and phenotypic modifications compared to rats, mouse models of hypertension are unusual when modeling cSVD and associated cognitive impairment experimentally. In the present study, we therefore characterized hypertension‐mediated cerebrovascular alterations and accompanying structural and functional consequences by simultaneously treating adult wild‐type mice (C57BL/6N) with Angiotensin II (AngII) and the nitric oxide synthases inhibitor L‐NAME for 4 weeks. Hypertension associated to cerebral alterations reminiscent of early‐onset cSVD and vascular cognitive impairment when combined with additional AngII bolus injections. Most importantly, preventing the elevation of blood pressure (BP) protected from the development of cSVD symptoms and associated cognitive decline. Our data strongly support the suitability of this particular mouse model of AngII‐induced hypertension as an appropriate animal model for early‐onset cSVD and hence, vascular cognitive impairment, pathologies commonly preceding vascular dementia., We gratefullyacknowledge the following funding support research grant from theSpanish Ministry of Economy (MICINN SAF2014-56279), a MarieCurie Action of the 7th Framework Program of the EuropeanCommission (AM; 2013_229673), a stipend for returning scientistsgranted from the German Academic Exchange Service (AM;PKZ2015_91606607), and the Else Kr€oner Fresenius Stiftung (JM;2014_EKES.16)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Uric acid Is protective after cerebral ischemia/reperfusion in hyperglycemic mice

  • Justicia, Carles
  • Salas-Perdomo, Angélica
  • Pérez-de-Puig, Isabel
  • Deddens, Lisette H.
  • Tilborg, & Geralda A.F. van
  • Castellví, Clara
  • Dijkhuizen, Rick M.
  • Chamorro, Ángel
  • Planas, Anna M.
Hyperglycemia at stroke onset is associated with poor long-term clinical outcome in numerous studies. Hyperglycemia induces intracellular acidosis, lipid peroxidation, and peroxynitrite production resulting in the generation of oxidative and nitrosative stress in the ischemic tissue. Here, we studied the effects of acute hyperglycemia on in vivo intercellular adhesion molecule-1 (ICAM-1) expression, neutrophil recruitment, and brain damage after ischemia/reperfusion in mice and tested whether the natural antioxidant uric acid was protective. Hyperglycemia was induced by i.p. administration of dextrose 45 min before transient occlusion of the middle cerebral artery. Magnetic resonance imaging (MRI) was performed at 24 h to measure lesion volume. A group of normoglycemic and hyperglycemic mice received an i.v. injection of micron-sized particles of iron oxide (MPIOs), conjugated with either anti-ICAM-1 antibody or control IgG, followed by T2*w MRI. Neutrophil infiltration was studied by immunofluorescence and flow cytometry. A group of hyperglycemic mice received an i.v. infusion of uric acid (16 mg/kg) or the vehicle starting after 45 min of reperfusion. ICAM-1-targeted MPIOs induced significantly larger MRI contrast-enhancing effects in the ischemic brain of hyperglycemic mice, which also showed more infiltrating neutrophils and larger lesions than normoglycemic mice. Uric acid reduced infarct volume in hyperglycemic mice but it did not prevent vascular ICAM-1 upregulation and did not significantly reduce the number of neutrophils in the ischemic brain tissue. In conclusion, hyperglycemia enhances stroke-induced vascular ICAM-1 and neutrophil infiltration and exacerbates the brain lesion. Uric acid reduces the lesion size after ischemia/reperfusion in hyperglycemic mice., This work was supported by the Spanish Ministerio de Economia y Competitividad (SAF2014-56279R and DPI2015-64358-C2-2-R) and the Netherlands Organization for Scientific Research (NWO; VIDI 917.76.347)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial Activation

  • Brait, Vanessa
  • Miró-Mur, Francesc
  • Pérez-de-Puig, Isabel
  • Notario, Laura
  • Hurtado Villarejo, Begoña
  • Pedragosa, Jordi
  • Gallizioli, Mattia
  • Jiménez-Altayó, Francesc
  • Arbaizar-Rovirosa, María
  • Otxoa de Amezaga, Amaia
  • Monteagudo, Juan
  • Ferrer-Ferrer, Maura
  • Rosa, Xavier de la
  • Bonfill-Teixidor, Ester
  • Salas-Perdomo, Angélica
  • Hernández-Vidal, Alba
  • García de Frutos, Pablo
  • Lauzurica, Pilar
  • Planas, Anna M.
RATIONALE: CD69 is an immunomodulatory molecule induced during lymphocyte activation. Following stroke, T-lymphocytes upregulate CD69 but its function is unknown. OBJECTIVE: We investigated whether CD69 was involved in brain damage following an ischemic stroke. METHODS AND RESULTS: We used adult male mice on the C57BL/6 or BALB/c backgrounds, including wild-type mice and CD69-/- mice, and CD69+/+ and CD69-/- lymphocyte-deficient Rag2-/- mice, and generated chimeric mice. We induced ischemia by transient or permanent middle cerebral artery occlusion. We measured infarct volume, assessed neurological function, and studied CD69 expression, as well as platelet function, fibrin(ogen) deposition, and VWF (von Willebrand factor) expression in brain vessels and VWF content and activity in plasma, and performed the tail-vein bleeding test and the carotid artery ferric chloride-induced thrombosis model. We also performed primary glial cell cultures and sorted brain CD45-CD11b-CD31+ endothelial cells for mRNA expression studies. We blocked VWF by intravenous administration of anti-VWF antibodies. CD69-/- mice showed larger infarct volumes and worse neurological deficits than the wild-type mice after ischemia. This worsening effect was not attributable to lymphocytes or other hematopoietic cells. CD69 deficiency lowered the time to thrombosis in the carotid artery despite platelet function not being affected. Ischemia upregulated Cd69 mRNA expression in brain endothelial cells. CD69-deficiency increased fibrin(ogen) accumulation in the ischemic tissue, and plasma VWF content and activity, and VWF expression in brain vessels. Blocking VWF reduced infarct volume and reverted the detrimental effect of CD69-/- deficiency. CONCLUSIONS: CD69 deficiency promotes a prothrombotic phenotype characterized by increased VWF and worse brain damage after ischemic stroke. The results suggest that CD69 acts as a downregulator of endothelial activation., The study was funded by the Spanish Ministerio de Economía y Competitividad (MINECO; grant SAF2014-56279-R and SAF2017-87459-R to A.M. Planas), Acción Estratégica de Salud (grants AES 1366/13 and AESI 1346/16 to P. Lauzurica), and Fundació la Marató de TV3 (grants 474-082230 and 20153031 to P. Garcia-de-Frutos). F. Miró-Mur had a PERIS award by the Health Department of the Generalitat de Catalunya. A. Otxoa-de-Amezaga has an FPI fellowship (MINECO).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microglial cell loss after ischemic stroke favors brain neutrophil accumulation

  • Otxoa de Amezaga, Amaia
  • Miró-Mur, Francesc
  • Pedragosa, Jordi
  • Gallizioli, Mattia
  • Justicia, Carles
  • Gaja-Capdevila, Núria
  • Ruíz-Jaén, Francisca
  • Salas-Perdomo, Angélica
  • Bosch, Anna
  • Calvo, María
  • Márquez-Kisinousky, Leonardo
  • Denes, Adam
  • Gunzer, Matthias
  • Planas, Anna M.
Stroke attracts neutrophils to the injured brain tissue where they can damage the integrity of the blood–brain barrier and exacerbate the lesion. However, the mechanisms involved in neutrophil transmigration, location and accumulation in the ischemic brain are not fully elucidated. Neutrophils can reach the perivascular spaces of brain vessels after crossing the endothelial cell layer and endothelial basal lamina of post-capillary venules, or migrating from the leptomeninges following pial vessel extravasation and/or a suggested translocation from the skull bone marrow. Based on previous observations of microglia phagocytosing neutrophils recruited to the ischemic brain lesion, we hypothesized that microglial cells might control neutrophil accumulation in the injured brain. We studied a model of permanent occlusion of the middle cerebral artery in mice, including microglia- and neutrophil-reporter mice. Using various in vitro and in vivo strategies to impair microglial function or to eliminate microglia by targeting colony stimulating factor 1 receptor (CSF1R), this study demonstrates that microglial phagocytosis of neutrophils has fundamental consequences for the ischemic tissue. We found that reactive microglia engulf neutrophils at the periphery of the ischemic lesion, whereas local microglial cell loss and dystrophy occurring in the ischemic core are associated with the accumulation of neutrophils first in perivascular spaces and later in the parenchyma. Accordingly, microglia depletion by long-term treatment with a CSF1R inhibitor increased the numbers of neutrophils and enlarged the ischemic lesion. Hence, microglial phagocytic function sets a critical line of defense against the vascular and tissue damaging capacity of neutrophils in brain ischemia., Supported by grants of the Ministerio de Economía y Competitividad (MINECO) (SAF2014-56279-R and SAF2017-87459-R).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs

  • Gallizioli, Mattia
  • Miró-Mur, Francesc
  • Otxoa de Amezaga, Amaia
  • Cugota, Roger
  • Salas-Perdomo, Angélica
  • Justicia, Carles
  • Brait, Vanessa
  • Ruíz-Jaén, Francisca
  • Arbaizar-Rovirosa, María
  • Pedragosa, Jordi
  • Bonfill-Teixidor, Ester
  • Gelderblom, Mathias
  • Magnus, Tim
  • Cano, Eva
  • Fresno, Carlos del
  • Sancho, David
  • Planas, Anna M.
CD11c dendritic cells infiltrate the brain after ischemic injury and share some features with microglia. Gallizioli et al. show that dendritic cells exhibit a transcriptional profile different from microglia and excel in antigen presentation. Microglia attract different DC subsets via chemokines, especially cDC1 that exert beneficial functions in cerebral ischemia.Brain CD11c cells share features with microglia and dendritic cells (DCs). Sterile inflammation increases brain CD11c cells, but their phenotype, origin, and functions remain largely unknown. We report that, after cerebral ischemia, microglia attract DCs to the inflamed brain, and astroglia produce Flt3 ligand, supporting development and expansion of CD11c cells. CD11c cells in the inflamed brain are a complex population derived from proliferating microglia and infiltrating DCs, including a major subset of OX40L conventional cDC2, and also cDC1, plasmacytoid, and monocyte-derived DCs. Despite sharing certain morphological features and markers, CD11c microglia and DCs display differential expression of pattern recognition receptors and chemokine receptors. DCs excel CD11c and CD11c microglia in the capacity to present antigen through MHCI and MHCII. Of note, cDC1s protect from brain injury after ischemia. We thus reveal aspects of the dynamics and functions of brain DCs in the regulation of inflammation and immunity., This work was funded by Ministerio de Ciencia, Innovación y Universidades (MICINN) co-financed by Fondo Europeo de Desarrollo Regional (FEDER) ( SAF2017-87459-R ), the European Union (EU) ( H2020-ITN-2018-813294-ENTRAIN ), and Fundació Marató TV3 ( 201723 to A.M.P. and D.S.). Work in the D.S. laboratory is funded by Centro Nacional de Investigaciones Cardiovasculares (CNIC), the European Research Council (ERC-2016-Consolidator Grant 725091 ), the EU ( 635122-PROCROP H2020 ), and MICINN-FEDER ( SAF2016-79040-R ). The EU ( FP7-PEOPLE-2013-ITN-n°07962 ) supported M. Gallizioli. The PERIS program of Generalitat de Catalunya supported F.M.-M. A.O.-d.-A. had a fellowship from MICINN-FPI ( BES-2015-074419 ). C.d.F. is supported by the AECC Foundation ( INVES192DELF ). We thank Anaxomics, the genomics and informatics BioCore Units of Centre for Genomic Regulation, the Cytomics and Experimental 7T MRI platforms of IDIBAPS, and the Advanced Optical Microscopy Unit-CCiT of the University of Barcelona for technical support. We thank Dr. U. Perpiñá for microscopy assistance. Plexxikon Inc. provided PLX5622 under a materials transfer agreement. Part of this work was performed at Centre de Recerca Biomèdica Cellex. The Centres de Recerca de Catalunya (CERCA) Program of Generalitat de Catalunya supports IDIBAPS.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension

  • Meissner, Anja
  • Miro, Francesc
  • Jiménez-Altayó, Francesc
  • Jurado, Andrés
  • Vila, Elisabet
  • Planas, Anna M.
Hypertension is a complex condition involving functional and structural alterations of the microvasculature and an activation of the immune system. T-lymphocytes play a crucial role during the development of hypertension in experimental models, yet the underlying mechanisms remain elusive. Lymphocyte egress from lymph nodes is controlled by sphingosine-1-phosphate (S1P), a natural lipid mediator regulating immune cell and vascular function in health and disease. We therefore investigated the involvement of S1P signalling in the pathogenesis of hypertension., This work was supported by the Spanish Ministry of Economy (MICINN SAF2014-56279) (A.M.P.), a Marie Curie Action of the 7th Framework Program of the European Commission (A.M.), the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) (A.M.) and a stipend for returning scientists granted from the German Academic Exchange Service (A.M.; PKZ2015_91606607)., Peer reviewed